Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials

Autor: Lawrence Scahill, Christopher J. McDougle, Yanhong Deng, James T. McCracken, Benedetto Vitiello, L. Eugene Arnold, Michael G. Aman, Elaine Tierney, James Dziura, Victoria Hallett
Rok vydání: 2012
Předmět:
Zdroj: Journal of Autism and Developmental Disorders. 43:739-746
ISSN: 1573-3432
0162-3257
DOI: 10.1007/s10803-012-1689-3
Popis: There is growing interest in measuring social disability as a core element of autism spectrum disorders in medication trials. We conducted a secondary analysis on the Aberrant Behavior Checklist Social Withdrawal subscale using data from two federally-funded, multi-site, randomized trials with risperidone. Study 1 included 52 subjects assigned to placebo and 49 subjects to risperidone under double-blind conditions. Study 2 included 49 subjects assigned to risperidone only and 75 subjects assigned to risperidone plus parent training. After 8 weeks of treatment, all active treatments were superior to placebo (effect sizes ranging from 0.42 to 0.65). The findings suggest that the Social Withdrawal subscale may be a useful measure of social disability in acute treatment trials.
Databáze: OpenAIRE